Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials

被引：6
作者：
Ayabe, Kengo [1 ]
Goto, Shinichi [1 ]
Goto, Shinya [1 ]
机构：
[1] Tokai Univ, Sch Med, Dept Med Cardiol, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2016年 / 5卷 / 02期
关键词：
Editorials; anticoagulation; atrial fibrillation; discontinuation; stroke; WARFARIN DISCONTINUATION; ATRIAL-FIBRILLATION; THERAPY; RIVAROXABAN; GUIDELINES; STATEMENT; UPDATE;
D O I：
10.1161/JAHA.116.003258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 20 条
  • [1] Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction
    Akincigil, Ayse
    Bowblis, John R.
    Levin, Carrie
    Jan, Saira
    Patel, Minalkumar
    Crystal, Stephen
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (02) : 115 - 121
  • [2] [Anonymous], 1988, LANCET, V2, P349
  • [3] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [4] Camm AJ, 2012, EUR HEART J, V33
  • [5] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [6] Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
    Fang, Margaret C.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Singer, Daniel E.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (06): : 624 - 631
  • [7] Rebound after cessation of oral anticoagulant therapy: The biochemical evidence
    Genewein, U
    Haeberli, A
    Straub, PW
    Beer, JH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 479 - 485
  • [8] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) : 2093 - 2104
  • [9] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [10] January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041
12